Error message

User warning: The following module is missing from the file system: admin_menu. For information about how to fix this, see the documentation page. in _drupal_trigger_error_with_delayed_logging() (line 1138 of /mnt/stor8-wc1-dfw1/408138/www.cannabissativa.co/web/content/includes/bootstrap.inc).

Industry News

8/02 10:15pm
Cannabis

Article: Stock-trading policy change looms over cannabis industry

submittedby/u/CanadaWeedStocks[link][comments]
https://www.reddit.com/r/weedstocks/comments/6r99cr/article_stocktrading_policy_...
8/02 10:08pm

Guess which weed stocks these are.. (all 30 days old or less)

G
uess which weed stocks are which... http://imgur.com/a/XwbFO submitted by /u/terflit [link] [comments]
https://www.reddit.com/r/weedstocks/comments/6r97ys/guess_which_weed_stocks_thes...
8/02 7:53pm

Isodiol International announces OTC ticket change

submittedby/u/420football[link][comments]
https://www.reddit.com/r/weedstocks/comments/6r8fpj/isodiol_international_announ...
8/02 7:37pm
Cannabis, Strains

Article: Aurora Cannabis (TSX:ACB) has the most potent strains of marijuana, PI analyst says initiated coverage of Aurora Cannabis with a “Buy” rating and a one-year price target of $3.25

submittedby/u/CanadaWeedStocks[link][comments]
https://www.reddit.com/r/weedstocks/comments/6r8buv/article_aurora_cannabis_tsxa...
8/02 7:37pm

Article: OrganiGram (TSXV:OGI) is still undervalued, GMP says maintained “Buy” rating and one-year price target of $4.00

submittedby/u/CanadaWeedStocks[link][comments]
https://www.reddit.com/r/weedstocks/comments/6r8bs4/article_organigram_tsxvogi_i...
8/02 7:37pm

Article: The Hydropothecary Corporation (TSXV:THCX) is undervalued, says Canaccord Genuity analyst gives “Speculative Buy” rating and a one-year price target of $3.10

submittedby/u/CanadaWeedStocks[link][comments]
https://www.reddit.com/r/weedstocks/comments/6r8bp1/article_the_hydropothecary_c...
8/02 5:52pm

Nektar to Announce Financial Results for the Second Quarter of 2017 on Tuesday, August 8, 2017, After Close of U.S.-Based Financial Markets

S
AN FRANCICO , Aug. 2, 2017 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter ended June 30, 2017, on Tuesday, August 8, 2017, after the close ...
https://finance.yahoo.com/news/nektar-announce-financial-results-second-21520041...
8/02 3:39pm
GBLX Cannabis, Enters, Facilities, Cultivation

GB Sciences Joins With Los Coyotes Band Of Cahuilla And Cupeno Indians As It Enters The Gigantic California Cannabis Market

L
AS VEGAS, Aug. 2, 2017 /PRNewswire/ -- GB Sciences, Inc. (GBX) is proud to announce an agreement with the os Coyotes Band of Cahuilla and Cupeno Indians (os Coyotes) for the purposes of establishing cannabis operations on the tribe's lands located near Warner Springs, California. This is the first time a publicly traded US cannabis cultivation company and a federally recognized Native American tribe have announced a commercial cannabis venture in California. GB Sciences will construct facilities on designated areas of tribal land for the business of cultivation, manufacturing and other commercial cannabis activities.
https://finance.yahoo.com/news/gb-sciences-joins-los-coyotes-193900794.html?.tsr...
8/02 3:33pm
Branding

What are your thoughts on the future of weed & branding in Canada?

T
he ability to build a quality brand will enable market share capture, consolidation and the ability to charge a premium price for product. here has been talk about potential restrictions to branding on weed in the future, depending on the severity of these restrictions, this could be a real concern. Without strong brands and clear, differentiated propositions, companies ultimately turn to reducing price to compete and take MS%, driving value out of the Category at a total level. -> What are your predictions around restrictions to branding? -> Is product quality going to be the only differing variable? As a marketer, this keeps me up a little at night! What are your thoughts? submitted by /u/Knowledge_1 [link] [comments]
https://www.reddit.com/r/weedstocks/comments/6r6onl/what_are_your_thoughts_on_th...
8/02 2:56pm
Cannabis, Medical Marijuana

Cannabis Sativa Acquires 51% of PrestoDoctor, A Premier Medical Marijuana Telemedicine Platform

submittedby/u/kellerlamp[link][comments]
https://www.reddit.com/r/weedstocks/comments/6r6ffz/cannabis_sativa_acquires_51_...
8/02 1:59pm

3 Exciting Biotechs Under $30: Zogenix's Drug Gives New Hope for Rare Indication

Z
ogenix is working on a drug that could help treat a heretofore untreatable indication, and trial results so far are good.
http://finance.yahoo.com/r/3b2a7985-5325-3355-bee8-2be4ae07176b/3-exciting-biote...
8/02 1:55pm

short squeeze incoming on "isol"

submittedby/u/Qc_weedstockvet[link][comments]
https://www.reddit.com/r/weedstocks/comments/6r5zf8/short_squeeze_incoming_on_is...
8/02 1:19pm
Testing

Rising Biosciences, Inc. Initiates Testing for FDA Approval of OTC Chronic Pain Relief Medications

submittedby/u/herb_knight[link][comments]
https://www.reddit.com/r/weedstocks/comments/6r5q32/rising_biosciences_inc_initi...
8/02 1:07pm

U.S. FDA Approves IMBRUVICA® (ibrutinib) as First Approved Treatment Specifically for Adults with Chronic Graft-Versus-Host-Disease (cGVHD) -- A Serious, Potentially Life-Threatening Condition -- After Failure of One or More Lines of Systemic Therapy

-
Approval for the treatment of cGVHD is the sixth U.S. disease indication for the medication and the first therapy specifically approved for adults with cGVHD after failure of one or more lines of systemic ...
https://finance.yahoo.com/news/u-fda-approves-imbruvica-ibrutinib-170700882.html...
8/02 1:02pm
Advertising, Cannabis, Investors, Management, Organic, Products

GrowGeneration Reports Record 2nd Quarter Revenue Q2 Revenue up 116%

G
roweneration Reports Record 2nd Quarter Revenue Q2 Revenue up 116% to $ 4.1 million; Same-store sales increase 54% DENVER, Aug. 02, 2017 (LOBE NEWSWIRE) -- roweneration Corp. (OTCQB:RW), (“rowen” or the “Company”) one of the largest specialty retail hydroponic and organic gardening stores, selling to both the commercial and home cannabis markets, with currently 13 locations, today reported financial results for its 2nd quarter ended June 30, 2017. 2nd Quarter 2017 Financial Highlights: Revenue of $4.1 million, up 116% compared to revenue of $1.9 million for the 2nd quarter of 2016 Same-store sales increased 54% from $1.7 million for the 2nd quarter of 2016 to $2.6 million for the 2nd quarter of 2017 Adjusted EBITDA for the quarter ended June 30, 2017 totaled $7,167 compared to adjusted EBITDA of $(33,447) for the quarter ended June 30, 2016 Net loss of $340,375, inclusive of $344,932 in non-cash depreciation and share-based compensation expense, compared to a net loss of $143,681 in the 2nd quarter of 2016, inclusive of $109,121 in non-cash depreciation and share-based compensation expense. The Company had $2.2 million in cash as of June 30, 2017 Darren Lampert, Co-Founder and CEO, said, “This was a record quarter of sales for roweneration, clearly demonstrating the demand for our products and the scalability of our business as we continue our expansion plans. The 2nd quarter was the sixth consecutive quarter of sequential revenue growth. Our company has reached a financial goal of break-even at this level of revenue.” “We have successfully opened and assimilated into our portfolio, our Denver South, Las Vegas and Trinidad stores, as well as the newly acquired stores in Seattle and Sonoma. All of these operations are performing well. We are aggressively expanding our business, with a focus in California, Nevada, Michigan, Rhode Island, Massachusetts, Maine, Oregon and the state of Washington,” added Mr. Lampert. We continue to forecast revenue for 2017 to be approximately $15 million.” 2nd Quarter 2017 Financial Results: Revenues for the quarter ended June 30, 2017 increased 116% to $4.1 million, compared to $1.9 million for the quarter ended June 30, 2016. Same Store Sales: For the period ended June 30, 2017, the Company had a total of seven stores opened more than one year, generating net revenue of approximately $2.6 million, compared to approximately $1.7 million for the same seven stores for the period ended June 30, 2016, an increase of approximately $904,000 or 54%. The five stores opened less than one year generated approximately $2.2 million for the quarter ended June 30, 2017. Sales from the recently opened San Bernardino store will start being reflected in the Company’s financial results in the third quarter. Cost of sales for the period ended June 30, 2017 increased $1.6 million to $2.96 million as compared to $1.34 million for the period ended June 30, 2016. The increase was due to the 116% increase in sales. ross profit was $1.15 million for the period ended June 30, 2017, resulting in a 28% gross margin, compared to $570,000, or a 30% gross margin, for the period ended June 30, 2016. The margin decrease was due to an increase in the number of commercial accounts, which are generally higher revenue, lower margin accounts. As the Company continues to scale, inventory and operating efficiencies are expected to begin to be recognized in higher margins and operating profit, and management expects margins to trend back up to normalized levels in the 2nd half of the year. Operating expenses include stores operations and corporate overhead. Operating expenses for the period ended June 30, 2017 increased $776,000 to $1.5 million, as compared to $712,000 for the period ended June 30, 2016. Store operating costs were $750,000 for the period ended June 30, 2017 compared to $381,000 for the period ended June 30, 2016. The increase is due to the increase in the number of stores. Store operating cost as a percentage of revenue was 18% for the period ended June 30, 2017 compared to 20% for the period ended June 30, 2016. Store operating costs are generally fixed in nature and do not rise commensurate with the increase in revenues. Corporate overhead, which includes non-cash share based compensation was $738,500 for the period ended June 30, 2017 compared to $331,200 for the period ended June 30, 2016. The increase was mainly due to an increase in non-cash share based compensation of $227,400 and increase in payroll expense of approximately $64,000 and an increase in general and administrative expenses such as advertising and promotion and travel and entertainment. Corporate overhead, exclusive of share based compensation was 10% of revenue for the period ended June 30, 2017 compared to 12% for the period ended June 30, 2016. For the period ended June 30, 2017, the Company reported a net loss of $340,375, or ($.02) per basic and diluted share, compared with a net loss of $143,681, or ($.02) per basic and diluted share, in the period ended June 30, 2016. The increase was mainly due to a $227,400 increase in non-cash share based compensation. Balance Sheet Summary As of June 30, 2017, the Company had $2.2 million in cash and $7.7 million in total current assets compared with $606,000 and $3.6 million, respectively, as of December 31, 2017. Current liabilities were $1.8 million at June 30, 2017, compared to $$843,000 at December 31, 2017. The Company ended the June 30, 2017 period with a working capital surplus of $5.9 million compared to $2.76 million for the period ended December 31, 2017. The Company raised $3.8 million in equity capital during the period ended June 30, 2017 through the issuance of common stock and the exercise of warrants. Adjusted EBITDA for the quarter ended June 30, 2017 totaled $7,167 compared to adjusted EBITDA of $(33,447) for the quarter ended June 30, 2016 (see definition and further discussion about the presentation of a EBITDA, a non-AAP term, below). Use of Non-AAP Financial Information The Company believes that the presentation of results excluding certain items in "Adjusted EBITDA," such as non-cash equity compensation charges, provides meaningful supplemental information to both management and investors, facilitating the evaluation of performance across reporting periods. The Company uses these non-AAP measures for internal planning and reporting purposes. These non-AAP measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-AAP measures used by other companies. The presentation of this additional information is not meant to be considered in isolation or as a substitute for net income or net income per share prepared in accordance with generally accepted accounting principles. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss): Three Months Ended 6/30/2017 6/30/2016 Net loss $ (340,375 ) $ (143,681 ) Interest 2,610 1,113 Depreciation and Amortization 19,524 11,121 EBITDA (318,241 ) (131,447 ) Share based compensation (option comp, warrant comp, stock issued for services) 325,408 98,000 Adjusted EBITDA $ 7,167 $ (33,447 ) submitted by /u/TallVanuy [link] [comments]
https://www.reddit.com/r/weedstocks/comments/6r5ldf/growgeneration_reports_recor...
8/02 12:41pm
ARNA

What's in Store for Arena (ARNA) this Earnings Season?

A
lthough Belviq, the only approved product in rena's (RN) portfolio, has an unimpressive performance so far, the company's efforts to improve the drug's performance might drive the stock in Q2.
https://finance.yahoo.com/news/apos-store-arena-arna-earnings-164104913.html?.ts...
8/02 12:22pm

4 ways the Ontario Survey on Legalization could be improved

submittedby/u/sanghs[link][comments]
https://www.reddit.com/r/weedstocks/comments/6r5azg/4_ways_the_ontario_survey_on...
8/02 11:19am

Canadian MJ and US S&P500 Correlation

A
nyone else trade stocks and noting this correlation? Thursday of last week we dumped in the market, and all the Canadian MJ names dumped at the same time, and bounced at the same time as well. I am noticing it on smaller time frames. I watch the markets pretty much tick for tick every day. submitted by /u/thechartguys [link] [comments]
https://www.reddit.com/r/weedstocks/comments/6r4veh/canadian_mj_and_us_sp500_cor...
8/02 11:19am

Looming legalization spurs 'massive interest' in marijuana retail opportunities in Calgary

submittedby/u/sanghs[link][comments]
https://www.reddit.com/r/weedstocks/comments/6r4vb6/looming_legalization_spurs_m...
8/02 11:16am
Cannabis

Cannabis industry to province: Make room for made-in-Manitoba weed

submittedby/u/sanghs[link][comments]
https://www.reddit.com/r/weedstocks/comments/6r4ug6/cannabis_industry_to_provinc...
8/02 11:14am
Hemp, Processing

Hemp Inc Processing facility Up and Running

submittedby/u/wurrboutit[link][comments]
https://www.reddit.com/r/weedstocks/comments/6r4u0u/hemp_inc_processing_facility...
8/02 10:11am

SEC suspends trading in four companies for failing to file financials

T
he U.S. Securities and Exchange Commission issued a temporary suspension of trading order on Wednesday for Aurios Inc. , EFLO Energy, Inc. , Inergetics, Inc. and Monar International, Inc. he order was ...
http://finance.yahoo.com/r/84d9d5b6-2ff6-33d9-af99-341a33ca307f/Story.aspx?guid=...
8/02 10:00am
Investors

3 Growth Stocks for Streetwise Investors

T
hese three growth stocks could deliver market-crushing returns.
http://finance.yahoo.com/r/e95420ec-9ef0-3852-ac4e-a1bd55431d2f/3-growth-stocks-...
8/02 9:00am
Cannabis, Development

Novus Partners with Silicon Valley Technology's PotBotics

N
ovus Acquisition and Development, Corp. , the nation's first healthcare insurance carrier/aggregator in the medical cannabis sector, today announced the signing of a strategic partnership agreement with ...
https://finance.yahoo.com/news/novus-partners-silicon-valley-technologys-1300002...
8/02 9:00am
ETST Research, Science

SeeThruEquity Issues Update on Earth Science Tech, Inc. (OTC: ETST)

N
EW YORK, Y / ACCESSWIRE / August 2, 2017 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued ...
https://finance.yahoo.com/news/seethruequity-issues-earth-science-tech-130000962...
8/02 9:00am
Cannabis, Events, Medical Marijuana, News

Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc., Discusses Recent News and Events in a New Audio Interview at SmallCapVoice.com

A
USTIN, Texas, ug. 02, 2017-- Medical Marijuana, Inc. and SmallCapVoice.com, Inc. announced today that a new audio interview with Medical Marijuana, Inc., the first-ever publicly traded cannabis company ...
https://finance.yahoo.com/news/dr-stuart-titus-chief-executive-130000268.html?.t...
8/02 8:43am
Marketing, Pharmaceuticals

No more freebies? India plans crackdown on marketing by drugmakers

I
ndia, one of the world's largest markets for pharmaceuticals is drawing up its first set of marketing rules for drugmakers, restricting gifts and trips offered to doctors and pharmacists to 1,000 rupees ($15), according to a draft proposal seen by Reuters. Such rules are common overseas, but are not set in stone in ndia, where campaigners have long demanded a crackdown on unethical selling practices that include gifts ranging from electrical appliances to foreign trips to woo physicians and pharmacists into prescribing and stocking specific medicines. The country has voluntary marketing guidelines for drugmakers, but critics say they are ineffective.
https://finance.yahoo.com/news/no-more-freebies-india-plans-124340532.html?.tsrc...
8/02 8:41am
Medical Marijuana

CannaRoyalty Investee, AltMed, Partners with Established Cultivator; Awarded Florida Medical Marijuana License

submittedby/u/mooncryptowow[link][comments]
https://www.reddit.com/r/weedstocks/comments/6r3w35/cannaroyalty_investee_altmed...
8/02 8:30am

Lexaria Bioscience Corp. Engages NetworkNewsWire for Corporate Communications Solutions

L
exaria Bioscience Corp. , an innovative company licensing proprietary technology for delivery of bioactive compounds including cannabinoids, announces that it has engaged the corporate communications ...
https://finance.yahoo.com/news/lexaria-bioscience-corp-engages-networknewswire-1...
8/02 8:00am

Need help finding a patent filed with the USTPO

I
've been having some trouble searching up a patent and was hoping one of you kind souls could help and explain the proper steps. The patent application number is 15/629.230 as it appears in this 8k filing. http://www.otcmarkets.com/edgar/GetFilingHtml?FilingD=12201995 Thanks for your time! submitted by /u/newwarfare [link] [comments]
https://www.reddit.com/r/weedstocks/comments/6r3oif/need_help_finding_a_patent_f...
8/02 7:43am
Cannabis, Investment

ABcann and Cannabis Wheaton Announce Closing of $15 Million Investment

submittedby/u/ABcannMedicinals[link][comments]
https://www.reddit.com/r/weedstocks/comments/6r3lj9/abcann_and_cannabis_wheaton_...